Gilead Sciences (LIM:GILD) Beta: N/A (As of Jul. 06, 2026)


LIM:GILD Gilead Sciences Inc LIM:GILD
69 GF Score
Price $131.50
GF Value $96.21
! 3 Warning Signs
View Full Analysis

What is Gilead Sciences Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-06), Gilead Sciences's Beta is Not available.

Gilead Sciences  (LIM:GILD) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Gilead Sciences Beta Related Terms

Gilead Sciences Beta Historical Data

* Premium members only.

The historical data trend for Gilead Sciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gilead Sciences Beta Chart

Gilead Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gilead Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LIM:GILD
69GF Score
Gilead Sciences Inc LIM:GILD
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gilead Sciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Gilead Sciences (LIM:GILD) Overvalued in 2026?

Based on GuruFocus' analysis, Gilead Sciences stock appears to be overvalued. The current stock price of $131.50 is trading 36.7% above its estimated GF Value™ of $96.21.

Key valuation signals for LIM:GILD:

  • Beta: N/A
  • GF Value™: $96.21 vs. price of $131.50 (36.7% above fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the LIM:GILD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gilead Sciences Business Description

Address 333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
69GF Score

Get the complete analysis for LIM:GILD

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$131.50
Price
$96.21
GF Value